HopeStage
Back to all studies
WithdrawnNCT01543724

Neural Correlates for Therapeutic Mechanisms of Lithium in Bipolarity

Medication studyAges 19–55South Korea
The study in practice

Understand this study

Who could participate?

This study is for people with bipolarity. Listed age limits: 19 years to 55 years. Other eligibility criteria apply.

What will I do during this study?

The study group receives lithium as a study medication.

Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: June 1, 2015
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
Ewha Womans University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
South Korea
Age range
From 19 Years to 55 Years
Official registry ID
NCT01543724
Official title
Show the full official title

A Multimodal Brain Imaging Study to Investigate Neural Correlates for Therapeutic Mechanisms of Lithium in Bipolar Disorder: Glycogen Synthase Kinase 3β Single Nucleotide Polymorphisms and Gray Matter Volume Increase Following Lithium Treatment in Bipolar Disorder

Recruitment & locations

Withdrawn

Seoul

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Ewha Womans University, a university.

Does this study involve medication?

Yes. The study involves medication, including lithium.

Who can participate?

This study is for people with bipolarity. Listed age limits: 19 years to 55 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as withdrawn.

Want to explore more studies?

Explore studies